394 related articles for article (PubMed ID: 10938119)
1. Multiple splicing defects in an intronic false exon.
Sun H; Chasin LA
Mol Cell Biol; 2000 Sep; 20(17):6414-25. PubMed ID: 10938119
[TBL] [Abstract][Full Text] [Related]
2. Characterization of hprt splicing mutations induced by the ultimate carcinogenic metabolite of benzo[a]pyrene in Chinese hamster V-79 cells.
Hennig EE; Conney AH; Wei SJ
Cancer Res; 1995 Apr; 55(7):1550-8. PubMed ID: 7882364
[TBL] [Abstract][Full Text] [Related]
3. Splicing mutants and their second-site suppressors at the dihydrofolate reductase locus in Chinese hamster ovary cells.
Carothers AM; Urlaub G; Grunberger D; Chasin LA
Mol Cell Biol; 1993 Aug; 13(8):5085-98. PubMed ID: 8336736
[TBL] [Abstract][Full Text] [Related]
4. An intronic polypyrimidine-rich element downstream of the donor site modulates cystic fibrosis transmembrane conductance regulator exon 9 alternative splicing.
Zuccato E; Buratti E; Stuani C; Baralle FE; Pagani F
J Biol Chem; 2004 Apr; 279(17):16980-8. PubMed ID: 14966131
[TBL] [Abstract][Full Text] [Related]
5. Molecular analysis of mutations affecting hprt mRNA splicing in human T-lymphocytes in vivo.
Rossi AM; Tates AD; van Zeeland AA; Vrieling H
Environ Mol Mutagen; 1992; 19(1):7-13. PubMed ID: 1732105
[TBL] [Abstract][Full Text] [Related]
6. Pseudoexon activation in disease by non-splice site deep intronic sequence variation - wild type pseudoexons constitute high-risk sites in the human genome.
Petersen USS; Doktor TK; Andresen BS
Hum Mutat; 2022 Feb; 43(2):103-127. PubMed ID: 34837434
[TBL] [Abstract][Full Text] [Related]
7. Silencer elements as possible inhibitors of pseudoexon splicing.
Sironi M; Menozzi G; Riva L; Cagliani R; Comi GP; Bresolin N; Giorda R; Pozzoli U
Nucleic Acids Res; 2004; 32(5):1783-91. PubMed ID: 15034146
[TBL] [Abstract][Full Text] [Related]
8. The deep intronic c.903+469T>C mutation in the MTRR gene creates an SF2/ASF binding exonic splicing enhancer, which leads to pseudoexon activation and causes the cblE type of homocystinuria.
Homolova K; Zavadakova P; Doktor TK; Schroeder LD; Kozich V; Andresen BS
Hum Mutat; 2010 Apr; 31(4):437-44. PubMed ID: 20120036
[TBL] [Abstract][Full Text] [Related]
9. Mutations that alter RNA splicing of the human HPRT gene: a review of the spectrum.
O'Neill JP; Rogan PK; Cariello N; Nicklas JA
Mutat Res; 1998 Nov; 411(3):179-214. PubMed ID: 9804951
[TBL] [Abstract][Full Text] [Related]
10. Defective splicing induced by 4NQO in the hamster hprt gene.
Menichini P; Inga A; Fronza G; Iannone R; Degan P; Campomenosi P; Abbondandolo A
Mutat Res; 1994 Apr; 323(4):159-65. PubMed ID: 7512685
[TBL] [Abstract][Full Text] [Related]
11. Mutations causing defective splicing in the human hprt gene.
Andersson B; Hou SM; Lambert B
Environ Mol Mutagen; 1992; 20(2):89-95. PubMed ID: 1380458
[TBL] [Abstract][Full Text] [Related]
12. Detailed molecular characterization of a novel IDS exonic mutation associated with multiple pseudoexon activation.
Grodecká L; Kováčová T; Kramárek M; Seneca S; Stouffs K; De Laet C; Majer F; Kršjaková T; Hujová P; Hrnčířová K; Souček P; Lissens W; Buratti E; Freiberger T
J Mol Med (Berl); 2017 Mar; 95(3):299-309. PubMed ID: 27837218
[TBL] [Abstract][Full Text] [Related]
13. Disease-causing mutations improving the branch site and polypyrimidine tract: pseudoexon activation of LINE-2 and antisense Alu lacking the poly(T)-tail.
Meili D; Kralovicova J; Zagalak J; Bonafé L; Fiori L; Blau N; Thöny B; Vorechovsky I
Hum Mutat; 2009 May; 30(5):823-31. PubMed ID: 19280650
[TBL] [Abstract][Full Text] [Related]
14. The intronic splicing code: multiple factors involved in ATM pseudoexon definition.
Dhir A; Buratti E; van Santen MA; Lührmann R; Baralle FE
EMBO J; 2010 Feb; 29(4):749-60. PubMed ID: 20094034
[TBL] [Abstract][Full Text] [Related]
15. Multiple cis elements regulate an alternative splicing event at 4.1R pre-mRNA during erythroid differentiation.
Deguillien M; Huang SC; Morinière M; Dreumont N; Benz EJ; Baklouti F
Blood; 2001 Dec; 98(13):3809-16. PubMed ID: 11739190
[TBL] [Abstract][Full Text] [Related]
16. Mutations which alter splicing in the human hypoxanthine-guanine phosphoribosyltransferase gene.
Steingrimsdottir H; Rowley G; Dorado G; Cole J; Lehmann AR
Nucleic Acids Res; 1992 Mar; 20(6):1201-8. PubMed ID: 1373235
[TBL] [Abstract][Full Text] [Related]
17. Multiple features contribute to efficient constitutive splicing of an unusually large exon.
Bruce SR; Peterson ML
Nucleic Acids Res; 2001 Jun; 29(11):2292-302. PubMed ID: 11376148
[TBL] [Abstract][Full Text] [Related]
18. Polypyrimidine tract-binding protein positively regulates inclusion of an alternative 3'-terminal exon.
Lou H; Helfman DM; Gagel RF; Berget SM
Mol Cell Biol; 1999 Jan; 19(1):78-85. PubMed ID: 9858533
[TBL] [Abstract][Full Text] [Related]
19. Mutational analysis of a plant branchpoint and polypyrimidine tract required for constitutive splicing of a mini-exon.
Simpson CG; Thow G; Clark GP; Jennings SN; Watters JA; Brown JW
RNA; 2002 Jan; 8(1):47-56. PubMed ID: 11873758
[TBL] [Abstract][Full Text] [Related]
20. A novel intronic cis element, ISE/ISS-3, regulates rat fibroblast growth factor receptor 2 splicing through activation of an upstream exon and repression of a downstream exon containing a noncanonical branch point sequence.
Hovhannisyan RH; Carstens RP
Mol Cell Biol; 2005 Jan; 25(1):250-63. PubMed ID: 15601847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
